Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells

Baghdadi, Muhammad; Wada, Haruka; Nakanishi, Sayaka; Abe, Hirotake; Han, Nanumi; Putra, Wira Eka; Endo, Daisuke; Watari, Hidemichi; Sakuragi, Noriaki; Hida, Yasuhiro; Kaga, Kichizo; Miyagi, Yohei; Yokose, Tomoyuki; Takano, Atsushi; Daigo, Yataro; Seino, Ken-ichiro

Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells

Baghdadi, Muhammad; Wada, Haruka; Nakanishi, Sayaka et al.

Cancer research, 2016, 76(20), 6030-6042

Permalink : https://hdl.handle.net/2115/67225

このアイテムのアクセス数:1,094件（2026-08-31 07:09 集計）

閲覧可能ファイル

ファイル	フォーマット	サイズ	閲覧回数	説明
CancerRes76_6030	pdf	811 KB	775
Captions_SupplFiles	pdf	6.40 KB	368	Captions for supplementary files
Supplementary_figure_S1	pdf	56.3 KB	308	Supplementary figure 1
Supplementary_figure_S2	pdf	221 KB	310	Supplementary figure 2
Supplementary_figure_S3	pdf	69.1 KB	313	Supplementary figure 3
Supplementary_figure_S4	pdf	98.5 KB	297	Supplementary figure 4
Supplementary_figure_S5	pdf	157 KB	263	Supplementary figure 5
Supplementary_figure_S6	pdf	188 KB	298	Supplementary figure 6
Supplementary_tables	pdf	37.3 KB	396	Supplemental tables
Supplementary_materials_and_methods	pdf	62.0 KB	501	Supplementary materials and methods

論文情報

ファイル出力 EndNote Basic出力 Mendeley出力

アクセス権	open access
URI	https://hdl.handle.net/2115/67225
タイトル	Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
その他のタイトル	An importance of IL-34 in cancer chemoresistance
著者	Baghdadi, Muhammad ; Wada, Haruka ; Nakanishi, Sayaka ; Abe, Hirotake ; Han, Nanumi ; Putra, Wira Eka ; Endo, Daisuke ; Watari, Hidemichi ; Sakuragi, Noriaki ; Hida, Yasuhiro ; Kaga, Kichizo ; Miyagi, Yohei ; Yokose, Tomoyuki ; Takano, Atsushi ; Daigo, Yataro ; Seino, Ken-ichiro
著者名 Baghdadi, Muhammad
e-Rad_Researcher 70392181 著者名 Wada, Haruka
著者名 Nakanishi, Sayaka
著者名 Abe, Hirotake
著者名 Han, Nanumi
著者名 Putra, Wira Eka
著者名 Endo, Daisuke
e-Rad_Researcher 10344508 著者名 Watari, Hidemichi
e-Rad_Researcher 70153963 著者名 Sakuragi, Noriaki
e-Rad_Researcher 30399919 著者名 Hida, Yasuhiro
e-Rad_Researcher 80224335 著者名 Kaga, Kichizo
e-Rad_Researcher 00254194 著者名 Miyagi, Yohei
著者名 Yokose, Tomoyuki
e-Rad_Researcher 50582607 著者名 Takano, Atsushi
e-Rad_Researcher 30345029 著者名 Daigo, Yataro
e-Rad_Researcher 20312845 著者名 Seino, Ken-ichiro
言語	英語
発行日	2016-10
出版者	American Association for Cancer Research
収録物名	Cancer research
巻(号)	76(20)
ページ	6030-6042
抄録	The ability of tumor cells to escape immune destruction and their acquired resistance to chemotherapy are major obstacles to effective cancer therapy. Although immune checkpoint therapies such as anti-PD-1 address these issues in part, clinical responses remain limited to a subpopulation of patients. In this report, we identified IL34 produced by cancer cells as a driver of chemoresistance. In particular, we found that IL34 modulated the functions of tumor-associated macrophages to enhance local immunosuppression and to promote the survival of chemoresistant cancer cells by activating AKT signaling. Targeting IL34 in chemoresistant tumors resulted in a remarkable inhibition of tumor growth when accompanied with chemotherapy. Our results define a pathogenic role for IL34 in mediating immunosuppression and chemoresistance and identify it as a tractable target for anticancer therapy.
資源タイプ	学術雑誌論文
出版タイプ	Accepted Manuscript
PISSN	0008-5472
関連情報	PMID 27550451
関連情報 (isVersionOf)	出版社版DOI https://doi.org/10.1158/0008-5472.CAN-16-1170